Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ardana holds pre-IND meeting with FDA for testosterone cream

Feb. 3, 2006

Shionogi describes new antiobesity agents in patent literature

Feb. 3, 2006

U.S. launch for Avandaryl

Feb. 2, 2006

AOD-9604 shows potential for osteoporosis

Feb. 2, 2006

Hemopure sales commence in South Africa

Feb. 1, 2006

Naglazyme approved in Europe for MPS VI

Feb. 1, 2006

Phase III study of ICA-17043 in sickle cell anemia cleared to continue

Feb. 1, 2006

Hematide begins phase II study to treat anemia in cancer patients

Feb. 1, 2006

New agents for treating endocrine-related disorders disclosed in patent literature

Feb. 1, 2006

Japanese filing for nateglinide in combination with biguanide agents

Jan. 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...